GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
W

Winston Pharmaceuticals WPHM · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.00

—

Close of 30 Oct 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in USD, from our data supplier.

FY2009

Revenue

$1.4m

FY2009FY2009

Net income

−$2.7m

FY2009FY2009

Free cash flow

−$4.2m

FY2009FY2009

Shareholders' equity

$488,571

FY2009FY2009

Income statement

Fiscal years

FY2009
Revenue$1.4m
Gross profit−$668,346
Operating income−$2.7m
Net income−$2.7m
Diluted earnings per share-0.04

Balance sheet

At each fiscal year end

FY2009
Total assets$1.7m
Total liabilities$1.2m
Shareholders' equity$488,571
Shares outstanding61m

Cash flow

Fiscal years

FY2009
Cash from operations−$4.2m
Capital spending−$738
Free cash flow−$4.2m

Latest quarters

By quarter end

Mar 2010Dec 2009Sept 2009Jun 2009Mar 2009Dec 2008Sept 2008Jun 2008
Revenue$316,706$339,045$350,512$365,044$340,000$350,000$10,000$20,000
Gross profit−$9,634−$7,246−$232,404−$222,716————
Operating income−$461,540−$562,187−$702,729−$687,709−$788,000−$1.3m−$1.1m−$1.5m
Net income−$460,691−$561,941−$702,481−$612,109−$778,000−$1.3m−$1.1m−$1.4m
Diluted earnings per share-0.01-0.01-0.01-0.01-0.01-0.02-0.02-0.03
Cash from operations———−$1.0m−$1.0m——−$1.0m
Total assets$842,274$1.7m$2.5m$3.3m$4.3m$5.8m$5.6m$6.8m
Cash and short-term investments————$4.2m$5.6m$5.5m$6.7m
Shareholders' equity$65,233$488,571$1.0m$1.7m$2.2m$2.9m$4.2m$5.8m

Growth per year

Compound annual rate

3 years5 years10 years
Revenue67.9%——
Operating income8.3%——
Net income24.6%——

Average margins

Over each period

1 year3 years5 years10 years
Gross margin-201.0%———

Share price return

Finished calendar years

2025202420232022202120202019201820172016
Return0%0%-100%299900%-78%3025%0%49%222%50%

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years.

  • 8-to-1 reverse split · 16 Jan 2009
  • 15-to-1 reverse split · 1 Dec 2006

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.